Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec;103(12):e590-e593.
doi: 10.3324/haematol.2018.196782. Epub 2018 Jul 12.

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD

Diego Villa  1 , Laurie H Sehn  2 , Christina Aquino-Parsons  3 , Petter Tonseth  4 , David W Scott  2 , Alina S Gerrie  2 , Donald Wilson  4 , François Bénard  4 , Randy D Gascoyne  5 , Graham W Slack  5 , Pedro Farinha  5 , James Morris  3 , Tom Pickles  3 , Joseph M Connors  2 , Kerry J Savage  2
Affiliations

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD

Diego Villa et al. Haematologica. 2018 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PET2 results, treatments, and outcomes. HL: Hodgkin lymphoma; PD: progressive disease; ASCT: autologous stem cell transplantation; TRM: treatment-related mortality (i.e., mortality related to ABVD +/− radiotherapy).
Figure 2.
Figure 2.
Outcomes for 239 patients with limited stage Hodgkin lymphoma managed with PET2-guided treatment. (A) Progression-free survival. (B) Overall survival.
See this image and copyright information in PMC

References

    1. Andre MPE, Girinsky T, Federico M, et al. Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 Trial. J Clin Oncol. 2017;35(16):1786–1794. - PubMed
    1. Meyer RM, Gospodarowicz MK, Connors JM, et al. ABVD alone versus radiation-based therapy in limited-stage Hodgkin’s lymphoma. N Engl J Med. 2012;366(5):399–408. - PMC - PubMed
    1. Radford J, Illidge T, Counsell N, et al. Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma. N Engl J Med. 2015;372(17):1598–1607. - PubMed
    1. Sasse S, Brockelmann PJ, Goergen H, et al. Long-term follow-up of contemporary treatment in early-stage Hodgkin lymphoma: updated analyses of the german Hodgkin study group HD7, HD8, HD10, and HD11 trials. J Clin Oncol. 2017;35(18):1999–2007. - PubMed
    1. Straus DJ, Jung SH, Pitcher B, et al. CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET. Blood 2018;132(10): 1013–1021. - PMC - PubMed